<div id="readability-page-1">Crispr Therapeutics (CRSP) pared a loss amid some takeover speculation. There's speculation that a takeover bid for Crispr (CRSP) could be moving along as the potential buyer has hired an adviser to help with a bid, according to traders, who cited a Betaville &#34;uncooked&#34; alert that was circulating on Monday. People following the matter have heard ta...</div>

CRISPR治療

<p>Crispr Therapeutics (CRSP) 正在經歷收購猜測，有報道稱潛在買家已聘請顧問，並可能與律師事務所 Skadden 合作進行出價。Betaville 之前曾提到一家市值在 1000 億至 2000 億美元之間的美國生物製藥公司對此表示興趣。交易員們正在密切關注事態發展</p>

在收購猜測中，CRISPR Therapeutics 減少了虧損